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The opportunistic pathogen Acinetobacter baumannii is responsible for a wide
range of infections that are becoming increasingly difﬁcult to treat due to extremely high
rates of multidrug resistance. Acinetobacter’s pathogenic potential is thought to rely on a “persist and resist” strategy that facilitates its remarkable ability to survive under a variety of harsh
conditions. The paa operon is involved in the catabolism of phenylacetic acid (PAA), an intermediate in phenylalanine degradation, and is the most differentially regulated pathway under
many environmental conditions. We found that, under subinhibitory concentrations of antibiotics, A. baumannii upregulates expression of the paa operon while simultaneously repressing
chaperone-usher Csu pilus expression and bioﬁlm formation. These phenotypes are reverted
either by exogenous addition of PAA and its nonmetabolizable derivative 4-ﬂuoro-PAA or by
a mutation that blocks PAA degradation. Interference with PAA degradation increases susceptibility to antibiotics and hydrogen peroxide treatment. Transcriptomic and proteomic analyses
identiﬁed a subset of genes and proteins whose expression is affected by addition of PAA or
disruption of the paa pathway. Finally, we demonstrated that blocking PAA catabolism results
in attenuated virulence in a murine catheter-associated urinary tract infection (CAUTI) model.
We conclude that the paa operon is part of a regulatory network that responds to antibiotic
and oxidative stress and is important for virulence. PAA has known regulatory functions in
plants, and our experiments suggest that PAA is a cross-kingdom signaling molecule.
Interference with this pathway may lead, in the future, to novel therapeutic strategies against
A. baumannii infections.
IMPORTANCE Acinetobacter baumannii causes a wide range of infections that are difﬁcult
to treat due to increasing rates of multidrug resistance; however, the mechanisms that this
pathogen uses to respond to stress are poorly understood. Here, we describe a new mechanism of stress signaling in Acinetobacter that is mediated by the metabolite phenylacetic
acid (PAA). We found that disrupting PAA catabolism interfered with A. baumannii’s ability
to adapt to stress, leading to decreased antibiotic tolerance and hydrogen peroxide resistance. We propose that investigating this stress response could lead to the development of
novel therapeutics. In fact, PAA derivatives constitute a group of FDA-approved nonsteroidal
anti-inﬂammatory drugs that could potentially be repurposed as antivirulence therapies to
target multidrug-resistant Acinetobacter infections.
KEYWORDS Acinetobacter, stress response, antibiotics, gene regulation, phenylacetic
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cinetobacter baumannii is an opportunistic pathogen that causes a wide range of
infections, including bacteremia, ventilator-associated pneumonia, and urinary tract
and wound infections (1, 2). A. baumannii is becoming increasingly difﬁcult to treat, and currently about 60% of clinical isolates are multidrug resistant (MDR). Additionally, A. baumannii
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causes particularly recalcitrant infections due to its ability to withstand antibiotic treatment
without designated antibiotic resistance genes (3–5). This is a great concern as surviving antibiotic treatment is known to facilitate the development of true antibiotic resistance (6).
However, the mechanisms used by A. baumannii to adapt to and tolerate hostile conditions,
such as antibiotic treatment, remain largely unknown.
Our lab has previously reported that A. baumannii ATCC 17978 (Ab17978) responds to subinhibitory concentrations of the antibiotic combination trimethoprim and sulfamethoxazole
(TMP/SMX) by repressing expression of Csu pili, leading to a subsequent decrease in bioﬁlm
formation (7). The Csu downregulation caused by TMP and SMX, which act synergistically to
inhibit synthesis of folate pathway intermediates and cause folate stress, can be overcome by
the addition of the essential intermediate tetrahydrofolate (7). Csu belongs to the chaperoneusher pathway (CUP) family of pili and mediates bacterial adherence to abiotic surfaces, such
as polystyrene and other materials that are commonly used in medical equipment (8–10). Csu
repression in response to TMP/SMX-induced folate stress occurs in multiple A. baumannii
strains; however, the mechanism underlying this response is unknown. In addition to Csu, we
found that TMP/SMX also increases the expression of the paa operon (11). The paa operon is
comprised of 13 genes (paaABCDEFGHJKXYI) encoding the enzymes necessary to degrade
phenylacetic acid (PAA), an intermediate in the catabolism of the amino acid L-phenylalanine.
PAA catabolism involves several steps, including the formation of PAA-coenzyme A (PAA-CoA)
followed by a unique epoxidation step, which is dependent on PaaABCDE. Ultimately, PAA catabolism leads to the production of succinyl-CoA and acetyl-CoA, which then feed into the tricarboxylic acid (TCA) cycle under aerobic conditions (12, 13). Multiple transcriptomic studies
performed with various A. baumannii strains have indicated that the paa operon is one of the
most differentially regulated pathways in response to various environmental conditions, such
as pleural ﬂuid, imipenem, and blue light (14–18). Furthermore, PAA catabolic genes are highly
expressed in cephalosporin-induced persister cells compared to planktonically grown bacteria
and are differentially regulated between motile and nonmotile populations (16, 19). Although
metabolic pathways are often regulated in response to environmental changes, the PAA pathway is the only amino acid catabolic pathway in Acinetobacter that is so consistently and
highly regulated under many diverse conditions.
Importantly, studies have implicated the paa operon in the pathogenesis of multiple
Gram-negative bacteria, including Burkholderia cenocepacia and A. baumannii (20–23). For
example, inactivation of the upper PAA catabolic pathway (paaABCDE) leads to decreased
virulence of B. cenocepacia in a Caenorhabditis elegans model (20, 23). In A. baumannii, the
paa operon is controlled by the virulence-associated two-component system (TCS) GacSA
and has been implicated in pathogenesis in murine septicemia and zebraﬁsh infection models (21, 22). It was proposed that the diminished virulence of the DpaaA strain in zebraﬁsh
was due to increased levels of secreted PAA, which acted as a neutrophil chemoattractant
(21). However, the effect of PAA on the physiology of A. baumannii, especially in modern
clinical isolates, is still not understood.
PAA has known signaling properties in plant cells, where it acts as an auxin to regulate plant growth and development (24, 25). In addition to their roles in plant development, plant-produced auxins are known to have regulatory effects on the surrounding
soil bacteria (24, 26). For example, Pseudomonas putida senses PAA using the Aer2 receptor, swimming toward PAA to utilize it as a carbon source (27). Furthermore, endogenously produced PAA inhibits expression of the type III secretion system (T3SS) in
Pseudomonas aeruginosa in a growth-phase-dependent manner (28). This piece of data
suggests that PAA may serve as an important signaling molecule in multiple bacteria;
however, little is known about its importance in Acinetobacter. In this work, we report a
novel role for PAA as a mediator of the stress response of A. baumannii.
RESULTS
Phenylacetic acid degradation is differentially regulated under antibiotic stress.
Previously, we observed via transcriptomic analysis that Ab17978 responds to TMP/SMX
treatment by upregulating the paa operon, which encodes the enzymes involved in
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phenylalanine catabolism, speciﬁcally the steps downstream of the intermediate PAA (7).
Two enzymes involved in the conversion of phenylalanine to PAA are the monoamine oxidase encoded by mao and the phenylacetaldehyde dehydrogenase encoded by feaB
(Fig. 1A) (29). Neither mao nor feaB was signiﬁcantly upregulated during TMP/SMX treatment according to RNA sequencing (RNA-Seq), suggesting that this response is not simply
an increase in phenylalanine metabolism (7). To conﬁrm our previous transcriptomic analyses, we performed reverse transcription-quantitative PCR (RT-qPCR) and determined that
paaA and paaB levels are increased approximately 7-fold at 2 h post-TMP/SMX treatment
compared to Ab17978 grown in LB (Fig. 1B). In contrast, levels of expression of mao and
feaB were not signiﬁcantly altered under these conditions. The observed increase in paa
operon expression was coupled with an ;15-fold decrease in expression levels of csuA/B,
which encodes the CsuA/B major pilin subunit of Csu pili (Fig. 1B). This is consistent with
our previous work demonstrating repression of Csu pilus expression under TMP/SMX treatment (7). These results prompted us to hypothesize that environmental signals, such as antibiotic treatment, cause an increase in the expression of the paa operon, impacting PAA
levels in the cell and leading to downstream responses, such as the repression of Csu pili
(Fig. 1C).
PAA levels regulate bioﬁlm formation and Csu expression. We conﬁrmed, by
Western blotting using an antibody for the CsuA/B major pilin, that TMP/SMX treatment almost completely abolished Csu expression in Ab17978, consistent with previously published results (Fig. 2A) (7). We found that the TMP/SMX-mediated effect on
Csu expression can be overcome by the addition of exogenous PAA in a concentration-dependent manner, reaching expression levels comparable to that of the LB control at 0.5 mM PAA (Fig. 2A). Similar results were obtained in Acinetobacter nosocomialis
M2, a strain of a medically relevant species, showing that this phenotype is not speciﬁc
to Ab17978 (Fig. 2B). Moreover, addition of increasing concentrations of ﬂuoro-phenylacetic acid (4F-PAA), a 4-ﬂuorinated-derivative of PAA (Fig. 2C), also restored CsuA/B
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FIG 1 The paa operon is upregulated under TMP/SMX treatment. (A) Schematic of phenylalanine and
PAA catabolism, where mao encodes the monoamine oxygenase, feaB encodes the phenylacetaldehyde
dehydrogenase, and the paa operon (paaABCDEFGHIJKY) encodes enzymes responsible for PAA’s
degradation to succinyl- and acetyl-CoA. (B) Relative gene expression of csuA/B major pilin and PAA
metabolism genes in WT Ab17978 grown in TMP/SMX compared to Ab17978 grown in LB, as
determined by qRT-PCR. Results are depicted as the mean 6 standard deviation (SD) from at least 3
biological replicates and are depicted as log2 fold change. Statistical analyses were performed on DCT
values using analysis of variance (ANOVA) and Tukey’s multiple-comparison test (*, P , 0.05; **,
P , 0.01). (C) Proposed model of PAA regulation in A. baumannii. Created with BioRender.com.
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expression under TMP/SMX treatment (Fig. 2D). Both PAA and 4F-PAA restore Csu
expression to LB-like levels at 0.5 mM (see Fig. S1A in the supplemental material), and
growth of Ab17978 is not inhibited under these conditions, suggesting that these molecules are not toxic at these concentrations (Fig. S1B). Ab17978 can grow in M9 minimal medium supplemented with PAA, but not 4F-PAA, as the only carbon source, indicating that 4F-PAA is not metabolized into TCA cycle intermediates (Fig. S1C). These
results indicate that restoration of Csu levels by PAA was not due to PAA being used as
an additional carbon source. Csu pili are one of the main determinants of bioﬁlm formation in Ab17978 (8, 9). We found that, in agreement with Csu Western blot data, exogenously added PAA or 4F-PAA induced bioﬁlm formation in Ab17978, as measured
by crystal violet binding (Fig. 2E). Bioﬁlm formation in a DcsuD mutant was completely
abolished in the presence and absence of exogenous PAA, conﬁrming that increased
bioﬁlm formation in response to PAA is dependent on Csu expression (see Fig. S2 in
the supplemental material). Together, these results implicate PAA in a putative signaling pathway induced by antibiotic stress and resulting in physiological changes (e.g.,
Csu expression).
PAA induces signiﬁcant proteomic changes. Our results show that Ab17978 modulates expression of Csu pili in a PAA-dependent fashion. To identify other proteins that
are differentially regulated in response to PAA, we performed quantitative differential proteomics. Wild-type (WT) Ab17978 was grown in LB, LB1TMP/SMX, LB1PAA, or LB1TMP/
SMX1PAA for 4 h before whole cells were harvested and analyzed via tandem mass spectrometry (MS/MS). In agreement with our previous results, proteomic analysis showed that
levels of expression of proteins involved in the biogenesis of Csu pili were signiﬁcantly
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FIG 2 PAA and 4F-PAA induce Csu pilus production under TMP/SMX treatment in multiple Acinetobacter
strains. (A) Western blot measuring expression of Csu pili in OD-normalized whole cells of Ab17978. WT
Ab17978 was grown for 4 h in LB with or without TMP/SMX (T/S) at 3 m g/mL and 15 m g/mL, respectively. TMP/
SMX-treated cells were also grown with increasing amounts of PAA. RNA polymerase (RNAP) was used as a
loading control, and Csu was probed with an anti-CsuA/B antibody targeting the major Csu pilin. (B) Western
blot analysis of Csu expression in whole cells of A. nosocomialis M2. Cultures were grown similarly to Ab17978,
except T/S concentrations were at 1 m g/mL and 4 m g/mL, respectively. (C) Molecular structures of PAA and the
ﬂuorinated PAA derivative 4-ﬂuorophenylacetic acid (4F-PAA). (D) Csu Western blot of Ab17978 whole cells
grown in LB, T/S, or T/S with increasing concentrations of 4F-PAA. All Western blots shown are representative
of at least three independent experiments. (E) Bioﬁlm formation of Ab17978 grown in the presence of 2 mM
PAA or 4F-PAA in the presence or absence of TMP/SMX. Bioﬁlm was measured via crystal violet staining in 96well plates after 24 h of static growth. OD550 measurements of crystal violet were normalized to OD600 values,
and the results are represented as the mean 6 SD of the OD550/OD600 ratios. Bioﬁlms are representative of at
least 3 independent experiments, and statistical analysis was done via t test with Welch’s correction (*,
P , 0.05; **, P , 0.01; ***, P , 0.005; ****, P , 0.001).
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downregulated in TMP/SMX-treated cells, while levels of expression of proteins involved in
PAA degradation were signiﬁcantly upregulated. Addition of PAA overcame the effect of
TMP/SMX on Csu proteins (Fig. 3). Several other proteins followed a similar pattern of
expression, where addition of PAA reverted or overcame the effects of TMP/SMX treatment
(see Table S1 in the supplemental material). The most prominent of these are 4 proteins
encoded together in an operon that are strongly induced by PAA (ACX60_RS12735 to
ACX60_RS12750). These proteins have putative hydrolase and oxidoreductase activities;
however, their functions remain uncharacterized. Additional proteins include those with
putative efﬂux pump activities (ACX60_RS16500 and ACX60_RS13840), a putative GTPbinding protein (ACX60_RS13705), and a TetR family regulator (ACX60_RS11270). Although
further work is necessary to characterize the roles of these proteins in the PAA-induced
response of A. baumannii, our results suggest that Csu downregulation is one of several
responses to folate stress that can be reversed by PAA.
Mutagenesis of paaB alters the expression of multiple genes in the presence of
antibiotics. Our experiments show that exogenous addition of PAA to A. baumannii
cultures increases Csu expression, reversing the repression of Csu caused by TMP/SMX.
To enable our investigation into the role of the PAA pathway in vivo, we sought to
manipulate PAA levels by generating a paaB mutant in Ab17978. paaB is part of the
multicomponent monooxygenase complex that is involved in one of the ﬁrst steps of
PAA catabolism (13, 21). Previous work in Burkholderia cenocepacia has shown that
paaB is essential for PAA catabolism, and paaB mutants accumulate PAA (23). We conﬁrmed that the Ab17978 DpaaB mutant grows similarly to the WT in LB (see Fig. S3A in
the supplemental material) but is unable to grow on PAA as the sole carbon source,
and in trans complementation of paaB (paaB1) restored growth on PAA (Fig. S3B). As
predicted, the accumulation of PAA in the DpaaB strain mimicked the effect of exogenous addition of PAA, leading to increased bioﬁlm formation (Fig. S3C). WT, DpaaB,
and paaB1 strains grown in LB exhibited comparable levels of Csu, as determined by
Western blotting (Fig. 4A). However, levels of Csu in the DpaaB strain were considerably higher than in the WT strain when cells were grown in TMP/SMX (Fig. 4A). The
paaB1 complemented strain was able to partially repress Csu expression, as the normalized Csu intensity of this strain was not signiﬁcantly different from that of the WT
(Fig. 4B). We next investigated how overexpression of the paa operon affects Csu
expression. Thus, we generated a DpaaX mutant in Ab17978. PaaX is known to be the
main regulator of the paa operon in Escherichia coli, where it was characterized to be a
repressor (30). Csu expression in the DpaaX mutant was approximately 50% of that in
the WT strain, further supporting the hypothesis that reduced PAA levels are partially
responsible for repressed Csu expression in Ab17978 (Fig. 4C and D). Together, these
data further support our hypothesis that PAA catabolism is important for the response
of Ab17978 to folate stress.
Proteomic changes may not necessarily reﬂect changes in gene expression, so we
performed transcriptomic experiments on whole cells of the Ab17978 WT and DpaaB
mutant strains grown in LB or LB1TMP/SMX (see Table S2 in the supplemental material). We found that, in the absence of antibiotic stress, 19 genes were signiﬁcantly upregulated in the DpaaB strain relative to the WT. In agreement with our proteomic
data, these included the 13 genes present in the paa operon (Table S2). Induction of
the paa operon is consistent with a metabolic response to the accumulation of PAA,
which occurs in DpaaB strains (21, 23). Additionally, adeIJK genes, which encode an
RND family efﬂux pump, were also increased in the paaB mutant. The AdeIJK efﬂux
pump of A. baumannii is thought to be a broad-spectrum pump with a preference for
amphiphilic compounds (31). Previously, both csu and paa genes were shown to be
downregulated in a DadeIJK mutant of strain AB5075 (32). This suggests a regulatory
connection between these pathways that is conserved between A. baumannii strains.
Future work is needed to understand the exact mechanisms behind the cross talk
between the PAA pathway, Csu pili, and efﬂux pumps in Acinetobacter. Several genes
related to CoA metabolism were also downregulated in the paaB mutant compared to
WT (ACX60_RS09235, ACX60_RS09240, and ACX60_RS06820). This is consistent with
May/June 2022 Volume 13 Issue 3

10.1128/mbio.01863-21

5

Downloaded from https://journals.asm.org/journal/mbio on 05 July 2022 by 128.252.154.28.

Stress Responses in Acinetobacter

mBio

FIG 3 PAA induces global changes in protein expression. Heat map of proteins detected by mass
spectrometry to be differentially expressed in Ab17978 whole cells treated with PAA, TMP/SMX (T/S),
or TMP/SMX1PAA compared to the LB control. To prepare protein samples, Ab17978 was grown for
4 h under each of the 4 conditions before being pelleted, lysed, and acetone precipitated. TMP and
SMX were used at 3 m g/mL and 15 m g/mL, respectively, and PAA was used at 0.5 mM. Paa proteins
are highlighted in red, and Csu is highlighted in green. Other proteins were labeled in gray if they
were (i) divergently regulated between TMP/SMX and TMP/SMX1PAA conditions and (ii) had putative
annotated functions. Each colored block represents the mean of 4 biological replicates. Student t
tests were used to compare groups, with a cutoff P value of ,0.05.
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FIG 4 PAA degradation is important for the response to TMP/SMX. (A) Csu expression of Ab17978
WT, DpaaB, and paaB1 strains via anti-CsuA/B Western blot. The three strains were grown in LB or
LB1TMP/SMX (3/15 m g/mL) for 4 h before whole cells were harvested and separated by SDS-PAGE.
(B) Normalized intensity and quantiﬁcation of panel A. Csu/RNAP intensity ratios were normalized to
Csu/RNAP values in the WT strain grown in LB. (C) Csu expression of the WT and DpaaX strains when
grown in LB. (D) Quantiﬁcation of panel C. The intensity of Csu was normalized to RNAP. Points
represent independent biological replicates, and signiﬁcance was determined via Mann-Whitney U
test (*, P , 0.05).

our proteomic data which shows these proteins downregulated in response to exogenous PAA addition (Fig. 3; Table S1). Contrasting the changes seen in LB, the WT and
DpaaB mutant displayed a broader repertoire of differentially expressed genes in the
presence of folate stress. In agreement with our model, the csu operon was more
highly expressed in the DpaaB strain. Remarkably, many other genes were differentially
regulated in the presence of the antibiotics (see Table S3 in the supplemental material). Although the function of most of these genes needs to be experimentally determined, we propose that genes that are differentially expressed in the WT and paaB mutant constitute the “PAA-dependent regulon.”
PAA catabolism is important for growth in antibiotics. In the previous experiments, we employed TMP/SMX to induce antibiotic stress. TMP/SMX is a cocktail of
drugs that synergistically inhibits synthesis of tetrahydrofolate (THF), which is essential
for nucleotide synthesis, leading to folate stress (7, 33). However, PAA could be part of
a general response to antibiotic stress rather than being speciﬁc to folate stress.
Supporting this concept, we found that Csu expression was repressed in Ab17978
grown in the presence of either kanamycin or gentamicin at a concentration that was
half of the MIC. Exogenous addition of 0.5 mM PAA overruled Csu repression (Fig. 5A).
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Similarly, the DpaaB mutant strain grown in sub-MICs of these aminoglycosides was unable
to repress Csu expression (Fig. 5B). Importantly, sub-MICs of kanamycin or gentamicin
caused a signiﬁcant inhibition of growth in the paaB mutant compared to the WT strain,
indicating that the paaB mutant strain cannot properly respond to aminoglycosideinduced stress (Fig. 5C to E). To understand if this PAA-dependent response is limited to
aminoglycosides and TMP/SMX, we performed Csu Western blots on WT and DpaaB cultures grown in sub-MICs of diverse antibiotics. We found that antibiotics targeting the bacterial cell wall (carbenicillin and imipenem) or outer membrane (colistin) did not alter Csu
expression in either strain (Fig. 5F) In contrast, antibiotics targeting DNA replication (ciproﬂoxacin) or protein synthesis (erythromycin and tetracycline) repressed Csu in the WT
strain, but not the DpaaB mutant (Fig. 5F). Our results indicate that PAA can mediate the
response of A. baumannii to stress induced by multiple classes of antibiotics, speciﬁcally
those with cytoplasmic targets. It has also been shown that MumR, a transcriptional regulator involved in manganese uptake and hydrogen peroxide (H2O2) tolerance, inﬂuences the
expression of the paa operon, and an Ab17978 mutant in the paa operon displayed
increased sensitivity to H2O2 and oxidative stress (34). Together with our observations, this
suggests that PAA may play a more general role in responding to different types of
stressors.
PAA degradation is important for stress tolerance and virulence of the uropathogenic
strain UPAB1. Although Ab17978 is a well-studied model strain used to study
Acinetobacter physiology, it lacks many of the virulence factors and antibiotic resistance cassettes that are present in recent clinical isolates of A. baumannii (35, 36). To
investigate antibiotic sensitivity in a modern strain, we generated a DpaaB mutant in
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FIG 5 PAA interrupts the antibiotic response of Ab17978. (A) Csu Western blot of Ab17978 grown in LB with kanamycin (1.5 m g/mL) or
gentamicin (1.75 m g/mL), with and without 0.5 mM PAA. (B) Csu expression of WT Ab17978 and DpaaB grown in LB, TMP/SMX,
kanamycin, or gentamicin. (C to E) Representative growth curves of the WT and DpaaB strains in LB, kanamycin (2.5 m g/mL), or gentamicin
(2 m g/mL). Cultures were normalized to 0.01 and grown for 16 h with shaking at 37°C. Asterisks indicate signiﬁcance based on multiple
unpaired t tests at each time point. Signiﬁcance of antibiotic growth curves was achieved starting at the 6th time point as determined by
Student's t test (P , 0.01). (F) Csu expression of WT Ab17978 and DpaaB strains grown in different antibiotics. CB, carbenicillin (64 m g/
mL); CIP, ciproﬂoxacin (0.125 m g/mL); COL, colistin (0.5 m g/mL); ERY, erythromycin (4 m g/mL); IMI, imipenem (0.125 m g/mL); TET,
tetracycline (0.125 m g/mL). All results are representative of at least 3 independent experiments.
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the recent clinical A. baumannii isolate UPAB1, a urinary isolate that is virulent in multiple mouse models (37). As seen in Ab17978, UPAB1 DpaaB does not exhibit any
growth defects in LB compared to WT (see Fig. S4A in the supplemental material), but
the DpaaB strain is not able to grow on M9 medium with PAA as the sole carbon
source. Importantly, chromosomal insertion of paaB (paaB1) complemented this phenotype (Fig. S4B). Similar to Ab17978 DpaaB, UPAB1 DpaaB also formed higher levels
of bioﬁlm compared to the WT and paaB1 strains, demonstrating that PAA catabolism
plays an important role in bioﬁlm formation in multiple Acinetobacter strains (Fig. S4C).
UPAB1 is highly resistant to many antibiotics, including kanamycin and gentamicin at
high concentrations (MIC of .400 m g/mL). Therefore, we used two antibiotics to which
UPAB1 is not resistant, the aminoglycoside apramycin and the glycopeptide zeocin. We
found that the paaB mutant displayed no growth under both apramycin and zeocin treatments compared to the WT and paaB1 strains, while all three strains grew similarly in LB
(Fig. 6A to C). This prompted us to measure the antimicrobial susceptibility proﬁles of WT
and paaB mutants in UPAB1 and Ab17978. Indeed, we found that the MIC of apramycin is
4 times lower in UPAB1 DpaaB than WT UPAB1, consistent with previous growth curves
(Table 1). Furthermore, modest decreases in MIC were observed in paaB mutants for ciproﬂoxacin, erythromycin, and zeocin in both UPAB1 and Ab17978 (Table 1). This piece of
data further supports our hypothesis that a PAA pathway-mediated antibiotic stress
response is conserved among A. baumannii strains and that interfering with this response
can decrease antibiotic resistance in a clinical isolate.
As mentioned previously, an Ab17978 mutant in the paa operon displayed increased
sensitivity to H2O2 (38). In agreement, we found that survival of UPAB1 DpaaB was reduced
by 2 logs compared to the WT strain after treatment with H2O2 (Fig. 6D and E). These
results further support the notion that PAA is also involved in the response of A. baumannii
to oxidative stress. Thus, we hypothesized that the inability of the paaB mutant to properly
respond to this kind of stress may impact the virulence of UPAB1. While systemic models
can serve as a useful benchmark for changes in virulence, they do not adequately represent the clinical manifestations of Acinetobacter disease. Because many A. baumannii
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FIG 6 PAA catabolism is important for stress tolerance in the uropathogenic strain, UPAB1. (A to C) Representative
growth curves of UPAB1 WT, DpaaB, and paaB1 strains. (D) Representative H2O2 killing of UPAB1 strains. The WT,
DpaaB, and paaB1 strains were grown in LB to mid-logarithmic phase before being treated with 0 mM or 175 mM
H2O2 for 30 min. Serial dilutions were spotted to measure survival. (E) Quantiﬁcation of H2O2 killing of UPAB1 strains
shown in recoverable CFU/mL. Points represent technical replicates from at least 3 biological replicates, with bars
representing the median. Statistical analysis using the Mann-Whitney U test was performed (*, P , 0.05).
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TABLE 1 Susceptibility of paaB mutants to antibioticsa
MIC (mg/mL) for:
Ab17978
Antibiotic
Colistin
Ciproﬂoxacin
Chloramphenicol
Erythromycin
Gentamicin
Imipenem
Kanamycin
Tetracycline
Zeocin
Apramycin
aMIC

WT
1
1
64
32
4
0.5
4
1
64
8

UPAB1
DpaaB
1
0.5
64
16
4
0.5
4
1
32
8

WT
2
32
64
16
.512
32
.512
16
32
32

DpaaB
2
16
64
8
.512
32
256
16
16
8

values that differ between WT and paaB mutants are bolded.

DISCUSSION
A. baumannii is a threatening nosocomial pathogen that is highly resistant to antibiotics and tolerant to a wide range of stressors. Although the repertoire of virulence factors of A. baumannii remains largely uncharacterized, we know that it does not have
the typical weapons like T3SS or T4SS that allow bacteria to interfere with the host
immune response. In fact, Acinetobacter’s pathogenic potential is thought to rely on a
“persist and resist” strategy that allows it to survive under a variety of harsh conditions
(36). Therefore, investigating the mechanisms used by A. baumannii to adapt to stress
will aid in our understanding of its pathogenesis and may lead to novel therapeutic
discoveries. We and others have shown that the paa operon, which is responsible for
PAA degradation, is one of the most differentially regulated pathways in response to
numerous stress conditions and is strongly upregulated under antibiotic treatment (15,
16, 18, 39, 40). In this study, we show that the metabolite PAA interferes with the
response of A. baumannii to various stressors. This activity is mimicked by its nonmeta-

FIG 7 PAA catabolism is crucial for virulence in a CAUTI model. Catheter-implanted mice were
infected with ;2  108 CFU of the indicated strains. Following 24 h of infection, total numbers of
CFU recovered were determined for the implants (left panel) and bladders (right panel). Each symbol
represents an individual mouse. For each strain, the median value is shown as the horizontal line.
Statistical analyses were performed using the Mann-Whitney U test (*, P , 0.05; **, P , 0.01).
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infections occur in immunocompromised hosts, who often have medical implants, we
employed a previously established catheter-associated urinary tract infection (CAUTI) murine model of infection that utilizes UPAB1, a urinary isolate, as a model (37). Brieﬂy, 6- to 8week-old female C57BL/6 mice were infected with 2  108 CFU after a small silicone catheter was placed in each mouse urethra, and organs were plated for CFU 24 h postinfection.
We found that the paaB mutant showed a signiﬁcant reduction in recoverable CFU from
the catheters and the bladders of infected mice (Fig. 7). The paaB1 complemented strain
showed CFU burdens comparable to WT levels. This conﬁrms that PAA degradation is a
critical pathway for the virulence of a modern clinical isolate in a CAUTI model.
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bolizable derivative 4F-PAA, which indicates this role is independent of PAA catabolism. We determined that increased concentrations of PAA, either through exogenous
treatment or through mutation of the PAA degradation pathway, induce expression of
Csu pili, overcoming antibiotic-mediated repression of Csu. Our results also conﬁrmed
that PaaX, the repressor of the paa operon, is involved in the regulation of Csu.
Furthermore, we established that paaB mutant strains, which are known to accumulate
PAA (21, 23), are sensitive to oxidative stress and exhibit reduced antibiotic tolerance
and resistance. Finally, we demonstrated that a functional PAA catabolism pathway is
critical for virulence of a clinical isolate in a murine CAUTI model. Taken together, this
is the ﬁrst evidence that PAA acts as a regulatory signal in multiple Acinetobacter
strains. We propose a model in which environmental cues lead to an increase in paa
operon expression, which controls cellular PAA levels and ultimately leads to changes
in gene expression to control pilus expression, bioﬁlm formation, and the response to
antibiotics and oxidative stress Although folate stress and certain conditions increase
paa expression (15–18, 39), reports have shown that paa expression is strongly
repressed as a response to other environmental changes (14, 38). Therefore, it is tempting to speculate that cells respond to both high and low concentrations of PAA by regulating the expression of different gene subsets (Fig. 8).
It is not yet understood how the PAA signaling cascade ﬁts into the global regulatory
networks in A. baumannii. However, there are several regulatory proteins that have been
shown to act upstream of the paa operon. We conﬁrm that PaaX is important for regulation of Csu, which is consistent with overexpression of the paa operon. It is possible that
PaaX interacts with other regulatory components to dynamically regulate paa operon
expression under a variety of environmental conditions. In fact, the paa operon is also
strongly regulated by the GacSA TCS in A. baumannii. GacS is an important virulence-associated histidine kinase that has roles in regulating bioﬁlm formation and motility, both in A.
baumannii and in Pseudomonas species (22, 41). Interestingly, a gacS mutant of A. baumannii showed up to 200-fold repression of paa genes compared to the WT, indicating that
GacS is a major regulator of the paa operon and could be responsible for regulating paa
genes in response to environmental changes (22). Additional regulators that act upstream
of the paa operon include BlsA, a photoreceptor that negatively regulates expression of
paa genes in response to blue light (14), and MumR, a manganese-responsive transcriptional regulator of the oxidative stress response in A. baumannii (34), further suggesting
that PAA degradation plays a role in adaptation to a variety of environmental conditions.
We have shown that the paa operon has downstream effects on the expression of
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FIG 8 Proposed model of PAA signaling where antibiotic treatment leads to increased expression of
the paa operon leading to decreased PAA levels, which ultimately regulates downstream responses
such as Csu pili. Exogenous addition of PAA or 4F-PAA or the disruption of paaB can interfere with
this response. We hypothesize that other conditions lead to decreased expression of the paa operon,
meaning tight control of PAA levels is important for environmental adaptation of Acinetobacter.

mBio

several factors, including Csu pili. It is well established that Csu expression is also regulated by the BfmRS TCS (42), a TCS involved in antibiotic tolerance, membrane homeostasis, and desiccation resistance (43, 44). While multiple factors likely affect Csu regulation, further work is necessary to determine if PAA interacts with components of the
Bfm system and how PAA induces Csu expression. The involvement of multiple regulators in paa operon regulation supports our model that PAA is an important player in
multiple signaling cascades.
Previous studies in the Gram-negative bacteria P. aeruginosa and B. cenocepacia,
have shown that PAA might interact with the quorum-sensing machinery of these
strains (23, 45). However, in B. cenocepacia, it was discovered that PAA is converted to
PAA-CoA to interfere with quorum-sensing-mediated virulence of this strain (46). We
cannot rule out that PAA-CoA, rather than PAA, is the signaling molecule that is responsible for the appreciable phenotypes in Acinetobacter. PAA could potentially be
converted to PAA-CoA by the paaK-encoded PAA-CoA ligase before exerting its effects
on the cell. However, for this to happen, paaK should be regulated independently from
the rest of the paa operon to allow for dynamic control over PAA-CoA levels. Our transcriptomic and proteomic data indicate that this is not the case. Furthermore, PAA was
shown to accumulate in a paaABCDE mutant (21). A metabolomic analysis would aid in
the determination of the exact levels of the different metabolites in the PAA pathway
under different environmental conditions.
Previous reports have linked PAA to virulence in the model strains Ab17978 and
ATCC 19606 (21, 22). It was shown that PAA produced by A. baumannii is sensed by
zebraﬁsh neutrophils, which are attracted to the site of infection, leading to greater
bacterial killing and improved host survival (21). Here, we show that inactivation of
PAA catabolism attenuates UPAB1 virulence in a murine CAUTI model. We propose
that attenuation is due to the reduced capacity of the DpaaB strain to respond to the
stresses the bacterium encounters during infection, which may include oxidative, osmotic, and other types of stress. More experiments are required to determine how host
and bacterial factors contribute to the phenotype of paa mutants in vivo and how this
plays a role in Acinetobacter pathogenesis.
We have observed for the ﬁrst time that PAA is involved in a signaling pathway in
A. baumannii. The biggest remaining question is how PAA mediates these physiological changes. PAA behaves as a signaling molecule in multiple organisms from plant to
bacteria; however, little is understood about PAA-receptor interactions. In plants, PAA
is a phytohormone that regulates many important processes involved in growth and
development (25). In fact, PAA can interact with different auxin coreceptors from the
transport inhibitor response1/auxin signaling F-box (TIR1/AFB) family, leading to
changes in gene expression in plant cells (25). In bacteria, the only characterized PAAreceptor interaction is in the rhizobacterium P. putida, where PAA, mostly produced by
plants, is sensed by the methyl-accepting chemotaxis receptor Aer2 (27). In this system,
P. putida senses PAA gradients using Aer2 and swims toward PAA to use it as a carbon
source. While this cascade is for metabolic purposes, it does suggest that bona ﬁde
PAA receptors may exist in other bacteria, such as A. baumannii, that sense and
respond to endogenously produced PAA. Therefore, we hypothesize that PAA is an
interspecies, cross-kingdom signaling molecule.
Understanding the molecular basis underlying the PAA-mediated response to stress could
open new avenues for drug development and research. In fact, some PAA derivatives are already part of a group of FDA-approved nonsteroidal anti-inﬂammatory drugs, some of which
have been used to treat bacterial infections in murine models (47, 48). The therapeutic potential of PAA or PAA derivatives in interfering with the stress response of drug-resistant bacteria
is extremely relevant to the growing ﬁeld of antimicrobial resistance, warranting further
research into their potential effects on Acinetobacter stress tolerance and pathogenesis.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The bacterial strains used in this study are listed in
Table S4 in the supplemental material. Unless otherwise noted, strains were grown in lysogeny broth
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(LB) liquid medium at 37°C with shaking (200 rpm). When necessary, strains were grown in kanamycin
(30 m g/mL), kanamycin (7.5 m g/mL), zeocin (50 m g/mL), gentamicin (15 m g/mL), trimethoprim (6 m g/
mL), and/or sulfamethoxazole (30 m g/mL). Overnight cultures used for phenotypic assays were always
grown without antibiotics.
Construction of paa mutants and complemented strains. The primers used in this study are listed
in Table S5 in the supplemental material. The paaB mutant of UPAB1 was constructed as done previously (49). Brieﬂy, an FLP recombination target (FRT) site-ﬂanked zeocin resistance cassette was ampliﬁed from a variant of pKD4 with primers harboring 18 to 25 nucleotides of homology to the ﬂanking
regions of the target gene, paaB. Upstream and downstream ﬂanking regions of paaB were also ampliﬁed, and the 3 fragments were assembled via overlap extension PCR to form linear DNA (50). For
Ab17978, a kanamycin cassette was ampliﬁed with 150-bp oligonucleotide primers with ﬂanking regions
of paaB or paaX to form the linear PCR product. Linear PCR products were then electroporated into competent Ab17978 or UPAB1 carrying pAT04, which expresses the RecAB recombinase (49). Mutants were
selected on zeocin (50 m g/mL) for UPAB1 or kanamycin (7.5 m g/mL) for Ab17978 and conﬁrmed by PCR.
To remove the antibiotic cassettes, mutants were transformed with the plasmid pAT03, which expresses
the FLP recombinase. Clean mutants were conﬁrmed by PCR and sequencing.
Complementation of paaB mutants was done using a mini-Tn7-based, four-parental conjugation technique for chromosomal insertion that was previously described (51). Brieﬂy, paaABC and 300 bp upstream of
paaA were ampliﬁed from the Ab17978 chromosome and inserted into pUC18-miniTn7-Gm (51) using Hi-Fi
DNA assembly mix (New England Biolabs) to make pUCT18-miniTn7-Gm-paaABC. For UPAB1, paaABCDEFG
and 300 bp upstream of paaA were ampliﬁed from the chromosome of UPAB1 and inserted into pUCT18miniTn7-Zeo (52). This vector was then linearized and religated to include only paaAB to create pUCT18miniTn7-Zeo-paaAB. To create paaB1 complemented strains, overnight cultures of either Ab17978 DpaaB or
UPAB1 DpaaB recipients, HB101(pRK2013), EC100D(pTNS2) for UPAB1 or SM10(pTNS3) for Ab17978, and either TOP10(pUCT18-miniTn7-Zeo-paaAB) for UPAB1 or TOP10(pUCT18-miniTn7-Gm-paaABC), were normalized to an optical density at 600 nm (OD600) of 2.0, and 100 m L of each culture was added to 600 m L LB. The
bacterial mixtures were washed 2 times with 1 mL LB, resuspended in 25 m L LB, spotted onto a low-salt Luria
agar plate, and incubated overnight at 37°C. For UPAB1, resuspended bacteria were plated on Luria agar
with chloramphenicol (12 m g/mL) to select against E. coli strains and zeocin (50 m g/mL) to select for mini-Tn7
recipients. For Ab17978, Vogel-Bonner minimal medium with 0.2% glycerol, chloramphenicol (12 m g/mL),
and gentamicin (100 m g/mL) was used for selection, similar to what was previously described (53). For
UPAB1, the paaB1 strain was then transformed with pAT03 to remove the zeocin cassette and make a clean
UPAB1 paaB1 strain. Complemented strains were veriﬁed by PCR and sequencing.
Csu Western blotting and quantiﬁcation. Ab17978 overnight cultures were diluted in 10 mL fresh
LB to an OD600 of 0.05 in 50-mL conical tubes and grown at 37°C with shaking for 4 h until they reached
an OD600 of 1.0. For growth under TMP/SMX conditions, the concentrations of 3 m g/mL for TMP and
15 m g/mL of SMX were used for Ab17978, and TMP/SMX (1/4 m g/mL) was used for M2. For other antibiotics, bacteria were treated with antibiotic concentrations under which the ﬁnal culture OD600 values
were between 65 and 85% of the untreated control. The cells were then pelleted by centrifugation and
resuspended in Laemmli buffer to a ﬁnal OD600 of 20. Then, 5 m L of whole-cell samples was loaded onto
15% acrylamide SDS-PAGE gels for separation, transferred to a nitrocellulose membrane, and probed
with polyclonal rabbit anti-CsuA/B (1:2,000) (42) and monoclonal mouse anti-RNA polymerase (antiRNAP) (1:2,600) (BioLegend, San Diego, CA). Western blots were then probed with IRDye-conjugated
anti-mouse and anti-rabbit secondary antibodies (both at 1:15,000) (LI-COR Biosciences, Lincoln, NE) and
visualized with an Odyssey CLx imaging system (LI-COR Biosciences). Western blot signals were quantiﬁed using LI-COR Image Studio software, and the ratio of Csu to RNA polymerase intensity was calculated for at least 4 biological replicates.
Bioﬁlm assays. Overnight cultures were normalized to an OD600 of 0.05 in LB and inoculated into
sterile, round-bottom polystyrene 96-well plates (Corning, Inc.) with a ﬁnal volume of 200 m L per well.
Plates were incubated for 24 h under static conditions at 37°C with humidity to prevent evaporation.
After incubation, culture was removed and transferred to another 96-well plate, and OD600 readings
were taken using a BioTek microplate reader. Wells were washed 5 times with water and stained with
300 m L 0.1% crystal violet solution dissolved in water for 15 min. After staining, wells were washed 5
times with water and left to completely dry overnight. Crystal violet staining was dissolved in 200 m L
30% acetic acid, and absorbance was measured at 550 nm.
Reverse transcription-quantitative PCR. Overnight cultures of Ab17978 were inoculated into
50 mL LB or LB plus TMP and SMX (3 m g/mL and 15 m g/mL, respectively) to a ﬁnal OD600 of 0.05 and
grown for 2 h at 37°C with shaking. Cells were quickly pelleted and treated with RNAprotect (Qiagen,
Inc.), followed by total RNA isolation using the ZR Fungal/Bacterial RNA MiniPrep kit (Zymo Research
Corp.). RNA samples were subjected to rigorous DNase treatment using a TURBO DNA-free kit to remove
contaminating DNA. For reverse transcription (RT)-PCR, cDNA was prepared from 1 m g RNA using a
high-capacity RNA-to-cDNA kit (Applied Biosystems), according to the manufacturer’s protocol. The
cDNA was diluted 1:10, and 1 m L was used as the template for quantitative PCR (qPCR) using PowerUp
SYBR green master mix (Applied Biosystems) on a ViiA7 real-time PCR machine (Applied Biosystems), following the manufacturer’s suggested protocol. The A. baumannii rpoB gene was used as a reference
gene (41). All gene-speciﬁc primers used for qPCR were designed using IDT PrimerQuest and are listed
in Table S5. Threshold cycle (CT) values were normalized to rpoB, and fold changes and log2(fold
changes) were calculated using the DDCT method.
Preparation of whole-cell lysates for comparative proteomics. Overnight cultures of WT Ab17978
were grown in LB and then subcultured to an OD600 of 0.05 in 100 mL of one of the following 4 culture
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conditions: LB, LB1TMP and SMX (3 m g/mL and 15 m g/mL), LB1PAA (0.5 mM), or LB1PAA1TMP/SMX.
Four individual 100-mL culture biological replicates were prepared for each condition. Cultures were
grown for 4 h at 37°C with shaking, pelleted, washed 1 with cold phosphate-buffered saline (PBS), and
pelleted again. Pellets were ﬂash frozen in liquid nitrogen and stored at 280°C until extraction. For protein extraction, pellets were thawed on ice and resuspended in 25 mL cold PBS plus Pierce protease inhibitor. Cells were lysed with two passages through a cell disruptor at 35,000 lb/in2 (Constant Systems,
Ltd., Kennesaw, GA). Unbroken cells were pelleted at 8,000 rpm for 10 min. Protein content of lysates
was quantiﬁed using a DC protein assay kit (Bio-Rad), and 200 m g of protein was acetone precipitated
twice. For acetone precipitation, 4 volumes of cold acetone was added to samples, and the samples
were incubated overnight at 220°C and centrifuged to discard the supernatant. Protein pellets were
resuspended in 200 m L of water, and acetone precipitation was repeated with 4 h of incubation at
220°C. Protein was pelleted at 16,000  g and dried at 70°C for 4 min before being stored at 220°C. No
less than 100 m g was used for comparative proteomics.
Digestion of proteome samples. Precipitated whole-cell lysates were resuspended in 6 M urea, 2 M
thiourea in 40 mM NH4HCO3 and then reduced for 1 h with 20 mM dithiothreitol (DTT). Reduced samples
were then alkylated with 50 mM chloroacetamide for 1 h in the dark. The alkylation reaction was then
quenched by the addition of 50 mM DTT for 15 min, and samples were digested with Lys-C (1/200 [wt/wt])
for 3 h at room temperature. Samples were diluted with 100 mM NH4HCO3 4-fold to reduce the urea/thiourea
concentration below 2 M, then trypsin (1/50 wt/wt) was added, and the mixture was allowed to digest overnight at room temperature. Digested samples were acidiﬁed to a ﬁnal concentration of 0.5% formic acid and
desalted with homemade high-capacity StageTips composed of 1 mg Empore C18 material (3M) and 5 mg of
Oligo R3 reverse-phase resin (Thermo Fisher Scientiﬁc) as described previously (54, 55). Columns were wet
with buffer B (0.1% formic acid, 80% acetonitrile) and conditioned with buffer A* (0.1% triﬂuoroacetic acid
[TFA], 2% acetonitrile) prior to use. Acidiﬁed samples were loaded onto conditioned columns and washed
with 10 bed volumes of buffer A*, and bound peptides were eluted with buffer B before being dried then
stored at 220°C.
LC-MS analysis of proteome samples. Dried proteome digests were resuspended in buffer A* and
separated using a two-column chromatography setup composed of a PepMap100 C18 20-mm by 75-m m
trap and a PepMap C18 500-mm by 75-m m analytical column (Thermo Fisher Scientiﬁc). Samples were
concentrated onto the trap column at 5 m L/min for 5 min with buffer A (0.1% formic acid, 2% dimethyl
sulfoxide [DMSO]) and then infused into an Orbitrap Fusion Lumos mass spectrometer (Thermo Fisher
Scientiﬁc) at 300 nL/min via the analytical column using a Dionex Ultimate 3000 UPLC (Thermo Fisher
Scientiﬁc). One hundred twenty-ﬁve-minute analytical runs were undertaken by altering the buffer composition from 2% buffer B (0.1% formic acid, 77.9% acetonitrile, 2% DMSO) to 22% B over 95 min, then
from 22% B to 40% B over 10 min, and then from 40% B to 80% B over 5 min. The composition was held
at 80% B for 5 min and then dropped to 2% B over 2 min before being held at 2% B for another 8 min.
The Orbitrap Fusion Lumos mass spectrometer was operated in a data-dependent mode automatically
switching between the acquisition of a single Orbitrap MS scan (300 to 1,600 m/z, a maximal injection
time of 50 ms, an automated gain control [AGC] set to a maximum of 4  105 ions, and a resolution of
120,000) and every Orbitrap tandem mass spectrometry (MS/MS) high-energy collisional dissociation
(HCD) scan of precursors (normalized collision energy [NCE] of 35%, a maximal injection time of 100 ms,
an AGC set to a maximum of 2  105 ions, and a resolution of 15,000) every 3 s.
Proteomic analysis. Whole-proteome samples were processed using MaxQuant (v1.6.3.4) (56) and
searched against the A. baumannii ATCC 17978 proteome (NCBI accession no. CP012004 [3,663 protein
sequences]). Searches were undertaken using “trypsin” enzyme speciﬁcity with carbamidomethylation
of cysteine as a ﬁxed modiﬁcation. Oxidation of methionine and acetylation of protein N termini were
included as variable modiﬁcations, and a maximum of 2 missed cleavages were allowed. To enhance the
identiﬁcation of peptides between samples, the “match between runs” option was enabled with a precursor match window set to 2 min and an alignment window of 20 min with the label-free quantitation
(LFQ) option enabled (57). The resulting outputs were processed within the Perseus (v1.6.0.7) analysis
environment (58) to remove reverse matches and common protein contaminants prior to further analysis. For LFQ comparisons, biological replicates were grouped, and missing values were then imputed
based on the observed total peptide intensities with a range of 0.3s and a downshift of 2.5s using
Perseus. Student t tests were undertaken to compare the proteomes between groups, with the resulting
data exported and visualized using ggplot2 (59) within R. The resulting MS data and search results have
been deposited into the PRIDE ProteomeXchange Consortium repository (60, 61).
Preparation of samples for RNA sequencing. WT Ab17978 and Ab17978 DpaaB were grown overnight in LB before being diluted into 10 mL of LB or LB1TMP/SMX (3 m g/mL and 15 m g/mL, respectively)
and grown for 2 h at 37°C with shaking. Four individual overnight and 10-mL culture biological replicates were prepared for each condition. Cultures were normalized, and the equivalent of 1 mL of an
OD600 of 1.0 was pelleted quickly at 8,000 rpm and treated with RNAprotect for 5 min at room temperature. Pellets were ﬂash frozen and stored at 280°C until extraction. For RNA extractions, pellets were
thawed on ice, resuspended in 600 m L TRIzol (Invitrogen) with 4 m L of glycogen at 5 mg/mL, and lysed
via bead beating. Samples were pelleted, and supernatants were treated with chloroform. RNA was
extracted from the aqueous phase using the RNeasy minikit (Qiagen, Inc.), and RNA quality was checked
by agarose gel electrophoresis and A260/A280 measurements. RNA was stored at 280°C with SUPERase-IN
RNase inhibitor (Life Technologies) until library preparation.
RNA sequencing and analysis. RNA sequencing (RNA-Seq) was performed as done previously (62).
Brieﬂy, 400 ng of total RNA from each sample was used for generation of cDNA libraries following the
RNAtag-Seq protocol. PCR-ampliﬁed cDNA libraries were sequenced on an Illumina NextSeq500,
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generating a high sequencing depth of ;7.5 million reads per sample. Raw reads were demultiplexed
by 59 and 39 indices, trimmed to 59 bp, and quality ﬁltered (96% sequence quality . Q14). Filtered reads
were mapped to the corresponding reference genome using bowtie2 with the “very-sensitive” option
(-D 20 –R 3 –N 0 –L 20 –i S, 1, 0.50). Mapped reads were aggregated by feature Count, and differential
expression was calculated with DESeq2 (63, 64). In each pairwise differential expression comparison, signiﬁcant differential expression was ﬁltered based on two criteria: jlog2 fold changej of .1 and adjusted
P value (padj) of ,0.05. All differential expression comparisons were made between the WT and paaB
mutant either in LB or under TMP/SMX treatment. The reproducibility of the transcriptomic data was
conﬁrmed by an overall high Spearman correlation across biological replicates (R . 0.95). Raw RNA-Seq
data sets are available at the Sequence Read Archive (BioProject accession no. PRJNA726989).
Differential expression data can be found in Tables S2 to S3 and at https://www.ncbi.nlm.nih.gov/
Traces/study/?acc=PRJNA726989&o=acc_s%3Aa.
Growth assays. Growth curves were performed in sterile, round-bottom, polystyrene, 96-well plates.
Bacterial strains were grown overnight in LB, washed in PBS, and diluted in fresh medium (LB or M9 minimal medium supplemented with PAA derivatives) to an OD600 of 0.01. Bacterial suspensions were then
inoculated into 96-well plates at a 150-m L ﬁnal volume before being grown at 37°C under shaking conditions. OD600 values were measured at 30-min intervals for 16 h with a BioTek microplate reader. For antibiotic growth curves, the same protocol was used, and bacteria were diluted in LB with the appropriate
antibiotic concentration. All experiments were performed on 3 independent days with at least 3 wells
per strain per condition.
Drug susceptibility assays (MIC determination). Antimicrobial susceptibility was determined using
the 2-fold broth dilution microtiter assay as previously described (32, 65). Brieﬂy, cells were inoculated at a
density of 105 cells/mL in a 96-well microtiter plate containing 2-fold dilutions of the appropriate antibiotics.
MICs were visually determined after plates were incubated at 37°C under shaking conditions for 16 h.
H2O2 killing assays. H2O2 killing assays were performed as done previously (38). Brieﬂy, overnight
cultures of the WT, DpaaB, and paaB1 UPAB1 strains were diluted 1:1,000 into 10 mL LB in 50-mL conical tubes and grown to mid-exponential phase (OD600 of 0.4 to 0.6). Cultures were then treated with
0 mM or 175 mM H2O2 for 30 min before being serially diluted and spot plated onto LB agar to enumerate CFU. Experiments were performed at least 3 independent times and were plated in duplicate.
Murine CAUTI model. CAUTI infections were performed as previously described for A. baumannii
(37). Bacterial strains were prepared for inoculation after static growth twice at 37°C by centrifugation at
6,500 rpm for 5 min. Cells were washed twice in 1 PBS and resuspended in PBS to the ﬁnal inoculum.
Brieﬂy, 6- to 8-week-old female C57BL/6 mice (Charles River Laboratories) were anesthetized by inhalation of 4% isoﬂurane, and a 4- to 5-mm piece of silicone tubing (catheter) was placed in the bladder via
transurethral insertion. Mice were infected immediately following implant placement with ;2  108
CFU bacteria in 50 m L via transurethral inoculation. At 24 h postinfection (p.i.), mice were euthanized,
and bladders and catheters were aseptically removed. The bacterial load present in each tissue was
determined by homogenizing each organ in PBS and plating serial dilutions on LB agar supplemented
with antibiotics when appropriate. All CAUTI studies were performed in accordance with the guidelines
of the Committee for Animal Studies at Washington University School of Medicine, and we have complied with all relevant ethical regulations. Mice were housed with a cycle consisting of 12 h each of light
and dark with access to standard food and water ad libitum.
Statistical analyses. Statistical analyses were performed using GraphPad Prism 9 software (GraphPad
Software, Inc., La Jolla, CA).
Data availability. The mass spectrometry proteomics data have been deposited into the PRIDE
ProteomeXchange Consortium repository and can be accessed with the identiﬁer PXD025651. Raw RNASeq data sets are available at the Sequence Read Archive (BioProject accession no. PRJNA726989).
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